UK markets closed

Envoy Medical, Inc. (COCH)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.6200-0.0700 (-2.60%)
At close: 04:00PM EDT
2.5200 -0.10 (-3.82%)
After hours: 05:58PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 51.35M
Enterprise value 51.76M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)172.90
Price/book (mrq)N/A
Enterprise value/revenue 174.29
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 2.31
52-week change 3-74.29%
S&P500 52-week change 323.76%
52-week high 311.7200
52-week low 30.7470
50-day moving average 33.8619
200-day moving average 33.6600

Share statistics

Avg vol (3-month) 387.36k
Avg vol (10-day) 326.54k
Shares outstanding 519.6M
Implied shares outstanding 619.6M
Float 87.16M
% held by insiders 163.69%
% held by institutions 16.82%
Shares short (15 May 2024) 434.97k
Short ratio (15 May 2024) 40.67
Short % of float (15 May 2024) 40.49%
Short % of shares outstanding (15 May 2024) 40.18%
Shares short (prior month 15 Apr 2024) 430.53k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-8,301.70%

Management effectiveness

Return on assets (ttm)-202.73%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)297k
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)-24.40%
Gross profit (ttm)N/A
EBITDA -19.36M
Net income avi to common (ttm)-22.93M
Diluted EPS (ttm)-1.1700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.95M
Total cash per share (mrq)0.25
Total debt (mrq)5.36M
Total debt/equity (mrq)N/A
Current ratio (mrq)1.11
Book value per share (mrq)-0.38

Cash flow statement

Operating cash flow (ttm)-20.49M
Levered free cash flow (ttm)-7.64M